Compare Edwards Lifesciences Corporation Common Stock (EW) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Taskus Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.14 (market cap $48.56B), while Taskus Inc trades at $8.16 (market cap $723.41M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 67.1× Taskus Inc's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| EW | TASK | |
|---|---|---|
Market Cap | $48.56B | $723.41M |
Volume | 6,520,488 | 201,303 |
Sector | Health | Technology |
52-Week High | $95.18 | $14.69 |
52-Week Low | $72.65 | $4.57 |
Enterprise Value | $45.01B | $1.09B |
Typical Hold Time | — | 34 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TaskUs trades at $8.08, up 2.41% today, with a bearish technical signal but strong fundamentals including a low P/E of 6.8 and robust ROE of 25.43%. Recent Q2 2026 earnings beat estimates with $0.33 EPS versus $0.29 expected, driven by 5% revenue growth to $308.9 million. The company shows consistent cash flow generation with $137 million from operations in 2025.
The stock appears undervalued with analyst consensus target of $9.33 offering 15% upside potential. Key risks include margin compression from higher labor costs and dependence on AI segment growth. Institutional ownership increased with Dimensional Fund Advisors raising its stake by 12.8% in Q1 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
